Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.45 CNY -3.37% Market Closed
Market Cap: 98.5B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note
Shanghai RAAS Blood Products Co Ltd
/
Cash Flow Statement
/
Effect of Foreign Exchange Rates

Shanghai RAAS Blood Products Co Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai RAAS Blood Products Co Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Effect of Foreign Exchange Rates
-¥2.8m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Beigene Ltd
HKEX:6160
Effect of Foreign Exchange Rates
¥44.1m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Effect of Foreign Exchange Rates
¥18.5m
CAGR 3-Years
N/A
CAGR 5-Years
47%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Effect of Foreign Exchange Rates
¥7.6m
CAGR 3-Years
N/A
CAGR 5-Years
50%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Effect of Foreign Exchange Rates
-¥1.4m
CAGR 3-Years
42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Effect of Foreign Exchange Rates
-¥833.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai RAAS Blood Products Co Ltd
Glance View

Market Cap
98.5B CNY
Industry
Biotechnology

Shanghai RAAS Blood Products Co., Ltd. is a key player in China's biopharmaceutical landscape, specializing in the production and supply of human blood products and diagnostic reagents. Founded in 1992, the company has grown to become one of the largest blood product manufacturers in the country, serving the increasing demand for high-quality and safe blood-derived therapies. The company’s extensive portfolio includes a range of products such as human albumin, immunoglobulins, and coagulants, which are essential for treating various medical conditions, from trauma care to chronic diseases. With a strong commitment to innovation and quality, RAAS has established robust research and development capabilities, ensuring that it stays at the forefront of advancements in blood product technologies. For investors, Shanghai RAAS represents a compelling opportunity in the rapidly expanding Chinese healthcare market. The company operates in a highly regulated environment, giving it a competitive edge through rigorous quality control and adherence to international standards. Furthermore, as China’s aging population grows and healthcare spending increases, the demand for reliable blood products is expected to rise significantly. RAAS has strategically positioned itself to capture this market growth, supported by a diversified customer base that includes hospitals and medical institutions. With its commitment to sustainability, innovation, and shareholder value, investing in Shanghai RAAS not only aligns with a growing industry but also offers the potential for solid returns as the company continues to expand its footprint in both domestic and international markets.

Intrinsic Value
5.68 CNY
Overvaluation 24%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Shanghai RAAS Blood Products Co Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-2.8m CNY

Based on the financial report for Jun 30, 2024, Shanghai RAAS Blood Products Co Ltd's Effect of Foreign Exchange Rates amounts to -2.8m CNY.

What is Shanghai RAAS Blood Products Co Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 10Y
-25%

The average annual Effect of Foreign Exchange Rates growth rates for Shanghai RAAS Blood Products Co Ltd have been 24% over the past three years , and -25% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.